We will take some profits, as MDR is up 90% from where we last bought it in January.
IBM, MetLife and Wells Fargo have increased theirs.
From AbbVie to Waste Management, let's review recent earnings reports from 8 portfolio holdings.
We maintain our Two rating on the stock.
We maintain that the shares offer growth at an attractive price.
First-quarter revenues also top consensus, with a favorable product mix.
04/27/16 - 10:02 AM EDT
We believe the stock still offers investors growth at a reasonable price.
We expect solid results from both companies, which have a string of meeting and exceeding consensus estimates.
We'll sell our entire holdings in Active Power and look for better opportunities.
04/26/16 - 09:51 AM EDT
This week's dividend reminders for model-portfolio names.